Literature DB >> 6481428

Misonidazole neurotoxicity in rats: Part I. Evaluation of misonidazole neurotoxicity in rats by analysis of brain stem auditory and cortical evoked potentials.

M S Edwards, D G Gordon, V A Levin, T L Phillips.   

Abstract

The effects of misonidazole (MISO) on brain stem evoked potentials (BAEPs) and cortical evoked potentials (CEPs) were evaluated in 16 Sprague-Dawley rats treated with the agent. As found in previous studies, serial BAEP values were diagnostic of the onset of MISO toxicity before clinical signs and symptoms appeared. However, MISO had no effects on CEPs, which remained essentially unchanged through the course of the experiment. At histologic examination, significant changes were found in the area of the brain stem, but there was no histologic evidence of damage to cortical or subcortical structures caused by MISO administration. The results of this study suggest that the neurotoxic effects of MISO are species-specific, and that while the rat model may be useful for comparison of the relative toxic effects of nitroimidazole radiosensitizers, it is not a model suited for measurement of neurotoxicity caused by MISO in humans and nonhuman primates.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6481428

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  11 in total

1.  Misonidazole-a drug for trial in radiotherapy and oncology.

Authors:  S Dische; M I Saunders; I R Flockhart; M E Lee; P Anderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-06       Impact factor: 7.038

2.  Peripheral neuropathy related to misonidazole: incidence and pathology.

Authors:  R C Urtasun; J D Chapman; M L Feldstein; R P Band; H R Rabin; A F Wilson; B Marynowski; E Starreveld; T Shnitka
Journal:  Br J Cancer Suppl       Date:  1978-06

3.  Letter: An investigation of the pharmacological and radiosensitizing effects of the 2-nitroimidazole Ro-07-0582 in primates.

Authors:  R Johnson; C Gomer; J Ambrus; J Pearce; D Boyle
Journal:  Br J Radiol       Date:  1976-03       Impact factor: 3.039

4.  Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.

Authors:  B Melgaard; H S Hansen; Z Kamieniecka; O B Paulson; A G Pedersen; X Tang; W Trojaborg
Journal:  Ann Neurol       Date:  1982-07       Impact factor: 10.422

5.  The brain stem auditory evoked response as a tool in neuro-behavioral toxicology and medicine.

Authors:  C S Rebert
Journal:  Prog Brain Res       Date:  1980       Impact factor: 2.453

6.  Evoked potentials in rats with misonidazole neurotoxicity. II. Somatosensory evoked potentials.

Authors:  S K Powers; M S Edwards; R A Baringer
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

7.  Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials.

Authors:  M S Edwards; S K Powers; R A Baringer; D L Jewett; C Bolger; T L Phillips
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

8.  Misonidazole neurotoxicity in rats: Part II. Effect of pre- and intermittent treatment with pentobarbital on misonidazole neurotoxicity in the rat.

Authors:  M S Edwards; D G Gordon; A Salamy; V A Levin; T L Phillips
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

9.  Evaluation of misonidazole peripheral neurotoxicity in rats by analysis of nerve trains evoked response.

Authors:  M S Edwards; C A Bolger; V A Levin; T L Phillips; D L Jewett
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-01       Impact factor: 7.038

10.  Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

Authors:  S Dische; M I Saunders; M E Lee; G E Adams; I R Flockhart
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

View more
  1 in total

1.  Misonidazole neurotoxicity in rats: Part II. Effect of pre- and intermittent treatment with pentobarbital on misonidazole neurotoxicity in the rat.

Authors:  M S Edwards; D G Gordon; A Salamy; V A Levin; T L Phillips
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.